{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:49:40Z","timestamp":1793638180341,"version":"4.5.1"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T00:00:00Z","timestamp":1361923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:sec>\n                    <jats:title>What's known on the subject? and What does the study add?<\/jats:title>\n                    <jats:p>\n                      The search for a biomarker in overactive bladder syndrome (\n                      <jats:styled-content style=\"fixed-case\">OAB<\/jats:styled-content>\n                      ) is an emerging field of interest, as bladder dysfunction is a common complaint that causes significant morbidity. A biomarker may give us insight as a diagnostic tool, and also inform us about how severe the condition is, how it may progress and how it may best be treated. The protein of interest here is nerve growth factor (\n                      <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                      ) and it has been shown to be a dynamic molecule in the bladder of patients with\n                      <jats:styled-content style=\"fixed-case\">OAB<\/jats:styled-content>\n                      . Urinary levels have been seen to rise in patients with\n                      <jats:styled-content style=\"fixed-case\">OAB<\/jats:styled-content>\n                      and fall in those who respond to treatment. However, there have also been many studies that examine this trend in numerous other conditions, e.g. interstitial cystitis, bladder outflow obstruction, renal stone disease and patients with neurological impairment after stroke. As a result the specificity of this as a potential urinary biomarker for\n                      <jats:styled-content style=\"fixed-case\">OAB<\/jats:styled-content>\n                      is questioned.\n                    <\/jats:p>\n                    <jats:p>\n                      This is a review of published studies, which discusses the pros and cons of\n                      <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                      as a potential urinary biomarker. The evidence is examined and the studies are summarised together in a\n                      <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\n                      able. Questions remain about the reliability, practicality and specificity of\n                      <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                      as a biomarker for\n                      <jats:styled-content style=\"fixed-case\">OAB<\/jats:styled-content>\n                      . These questions need to be addressed by further studies that could clarify the points raised.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            To review the current literature on the use of urinary nerve growth factor (\n                            <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                            ) as a potential biomarker for overactive bladder syndrome (\n                            <jats:styled-content style=\"fixed-case\">OAB<\/jats:styled-content>\n                            ).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            A comprehensive electronic literature search was conducted using the PubMed database to identify publications relating to urinary\n                            <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            There are a growing number of publications that have measured urinary\n                            <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                            levels in different types of bladder dysfunction. These range from\n                            <jats:styled-content style=\"fixed-case\">OAB<\/jats:styled-content>\n                            , bladder pain syndrome, idiopathic and neurogenic detrusor overactivity, bladder oversensitivity and bladder outflow obstruction. Urinary\n                            <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                            levels do appear to be raised in these pathological states when compared with healthy control samples.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            In patients with\n                            <jats:styled-content style=\"fixed-case\">OAB<\/jats:styled-content>\n                            , these raised urinary\n                            <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                            levels appear to also reduce after successful treatment with antimuscarinics and botulinum toxin A, which indicates a potential use in monitoring responses to treatment.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            However, raised levels are not limited to\n                            <jats:styled-content style=\"fixed-case\">OAB<\/jats:styled-content>\n                            , which questions its specificity.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Urinary\n                            <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                            measurements are performed with an enzyme\u2010linked immunosorbent assay using polyclonal antibodies to\n                            <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                            . The technique requires standardisation, and the different antibodies to\n                            <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                            require validating.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Also a definition of what is the \u2018normal\u2019 range of\n                            <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                            in urine is still required before it can be used as a diagnostic and prognostic tool.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Whilst the evidence for an increased urinary\n                            <jats:styled-content style=\"fixed-case\">NGF<\/jats:styled-content>\n                            in\n                            <jats:styled-content style=\"fixed-case\">OAB<\/jats:styled-content>\n                            appears convincing, many questions about its validity remain including: specificity, sensitivity, cost\u2010 and time\u2010effectiveness.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Many criteria for what constitutes a biomarker still need to be evaluated and met before this molecule can be considered for this role.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2012.11672.x","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T08:33:38Z","timestamp":1361954018000},"page":"372-380","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Nerve growth factor (\n                    <scp>NGF<\/scp>\n                    ): a potential urinary biomarker for overactive bladder syndrome (\n                    <scp>OAB<\/scp>\n                    )?"],"prefix":"10.1111","volume":"111","author":[{"given":"Jai H.","family":"Seth","sequence":"first","affiliation":[{"name":"Department of Uro\u2010Neurology National Hospital for Neurology and Neurosurgery UCL Institute of Neurology  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sahai","sequence":"additional","affiliation":[{"name":"Department of Urology and Medical Research Council (MRC) Centre for Transplantation King's College London, King's Health Partners, Guy's Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Urology and Medical Research Council (MRC) Centre for Transplantation King's College London, King's Health Partners, Guy's Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"van der Aa","sequence":"additional","affiliation":[{"name":"Department of Urology University Hospitals K.U. Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"de Ridder","sequence":"additional","affiliation":[{"name":"Department of Urology University Hospitals K.U. Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalesh N.","family":"Panicker","sequence":"additional","affiliation":[{"name":"Department of Uro\u2010Neurology National Hospital for Neurology and Neurosurgery UCL Institute of Neurology  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prokar","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"Department of Urology and Medical Research Council (MRC) Centre for Transplantation King's College London, King's Health Partners, Guy's Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare J.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Department of Uro\u2010Neurology National Hospital for Neurology and Neurosurgery UCL Institute of Neurology  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican0679-68"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.21022"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.10052"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.04.037"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-009-0446-5"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(10)60133-7"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20747"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1999.7254"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000155170.15023.e5"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2011.02779.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3023-06.2006"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00367.2009"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.02.003"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64244-9"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2011.03.070"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64369-8"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000088340.26588.74"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(06)00258-8"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.04.038"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1997.00097.x"},{"key":"e_1_2_8_22_1","first-page":"75","article-title":"Substance P and inflammatory pain: potential of substance P antagonists as analgesics","volume":"41","author":"Henry JL","year":"1993","journal-title":"Agents Actions Suppl"},{"key":"e_1_2_8_23_1","first-page":"e69","article-title":"Can urinary nerve growth factor be a biomarker for overactive bladder?","volume":"12","author":"Kuo HC","year":"2010","journal-title":"Rev Urol"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.1.2.182"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20741"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.07757.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.21118"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08380.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(06)00563-5"},{"key":"e_1_2_8_30_1","first-page":"4989","article-title":"Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients","volume":"17","author":"Jacobs BL","year":"2010","journal-title":"Can J Urol"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)61915-3"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044687"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.02.037"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(200006)183:3<289::AID-JCP1>3.0.CO;2-6"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20599"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.01.069"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66664-3"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08533.x"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.20.10955"},{"key":"e_1_2_8_40_1","first-page":"825","article-title":"Endogenous nerve growth factor in patients with Alzheimer s disease","volume":"32","author":"Serrano\u2010Sanchez T","year":"2001","journal-title":"Rev Neurol"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1373\/49.1.19"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1373\/49.1.1"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.08.187"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.02.031"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09585.x"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08675.x"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08851.x"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20519"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.01.146"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00992-4"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2005.01140.x"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2012.11672.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2012.11672.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:13:02Z","timestamp":1761754382000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2012.11672.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1111\/j.1464-410X.2012.11672.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2012.11672.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,27]]},"assertion":[{"value":"2013-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}